SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures — Stella

Home/Focal Onset Seizures/

View on ClinicalTrials.gov

Recruiting

Back to Focal Onset Seizures trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Medsol Clinical Research Center, Port Charlotte, Florida

Key details

Phase

Safety & dosing

Sponsor

Supernus Pharmaceuticals, Inc.

Enrollment target

~100 participants

Started

July 2025

Primary completion

December 2027

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.